Citius Oncology, Inc. CTOR Warrants and Rights Outstanding
Warrants and Rights Outstanding at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s warrants and rights outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Citius Oncology, Inc.'s warrants and rights outstanding?
- Citius Oncology, Inc. (CTOR) reported warrants and rights outstanding of 816.7K in Q4 2025.
- What does warrants and rights outstanding mean?
- This metric represents the total number of outstanding warrants and rights that grant holders the option to purchase company equity at a specified price. It serves as a measure of potential future dilution for existing shareholders. Investors monitor this to assess the impact of potential equity issuance on earnings per share and overall ownership structure.